Quanex Building Products sold about 1% more than it did a year ago last quarter. The stock is up roughly 23% to $23.08 today, as reported by Benzinga, from an $18.76 close — Investing.com had it +20.6% to $22.63 in the after-hours session that followed the release. Either way, a company adds a fifth of its value on a quarter where sales barely moved.

So the sales line isn't what moved it. Here's what did.

What happened

Q3 net sales were $501.8m, up 1.3% from $495.3m, roughly in line with the $498.4m estimate. Adjusted diluted EPS came in at $0.79 against a $0.65 forecast — a 21.5% beat — and up from $0.69 a year ago (Investing.com).

Read those two together: revenue flat, profit per share up about 14%. Everything happened between the top line and the bottom line.

Why it moved

Margins. Gross margin went to 28.2% from 27.9%, and adjusted EBITDA rose to $72.7m from $70.3m — a 14.5% margin on flat sales. CEO George Wilson told the call the company had "meaningfully narrowed the cost price gap" by pushing through price increases from mid-single digits to the low teens, phased in over the quarter. That's the whole trick: tariffs and input costs raised the cost of a window component, and Quanex has now repriced enough of its book to cover it.

Then cash. Free cash flow was $47.8m and the company repaid $42.25m of debt in three months, leaving total debt at $672.2m and leverage at 2.8x net debt to trailing adjusted EBITDA, with liquidity up 10.5% to $363.1m.

One number to not misread

GAAP EPS was $0.58, against a loss of $(6.04) a year ago — net income of $26.5m versus a $(276.0)m loss. That looks like a $300m turnaround. It mostly isn't. The year-ago quarter carried a large non-cash goodwill writedown — an accounting haircut on the value of past acquisitions — which is now lapping out of the comparison. The operating improvement is the $0.69 to $0.79 adjusted number, not the $6.62 headline swing. Anyone quoting the bigger figure is quoting an accounting artefact.

The business

Quanex doesn't sell windows. It sells the parts inside them to the OEMs who do — insulating glass spacers, vinyl and aluminium extruded profiles, screens, and door and window hardware. Three segments moved differently this quarter: Hardware Solutions sales fell 2.7% on lower volumes and tariff reimbursements, Extruded Solutions rose 2.8%, and Custom Solutions rose 8.5%. So a single soft segment was offset elsewhere — this is a components portfolio, not a one-product bet.

Is it expensive?

At about $23, Quanex is a roughly $1bn company (StockAnalysis had market cap near $966m mid-session) on a trailing P/E of ~21 and a forward P/E of ~10.6, with TTM revenue of $1.86bn and a 1.51% dividend yield. A forward multiple around 10 is genuinely undemanding — it prices in very little earnings growth.

Against the obvious bigger name, Fortune Brands Innovations (FBIN): a $5.04bn company on a trailing P/E of ~34, forward ~14, with TTM revenue of $4.39bn that shrank 2.3%. So the much larger, better-known building-products name trades about a third richer on forward earnings while its revenue goes backwards. Quanex is cheaper and just grew. The catch is size: a $1bn company carrying $672m of debt has far less room for error than a $5bn one.

Who this touches

• US window and door OEMs and their suppliers — Fortune Brands, JELD-WEN, Gibraltar Industries, Apogee. Quanex sits upstream of all of them, so its order book is an early read on repair-remodel and new-build window demand.
• Anyone tracking tariff pass-through. This is a clean worked example: costs rose, the company took mid-single to low-teens price, and roughly a year later the margin came back. That lag — cost hits first, price catches up later — is the same arithmetic facing any exporter or importer repricing into tariffs, Indian ones included.
• Housing-cycle bulls. Management called the weakness "demand deferred rather than demand destroyed." That's a claim, not a fact, and Q4 tests it.

The one risk that flips it

Leverage cuts both ways. Guidance for Q4 is 2–3% revenue growth with 50–75 basis points of adjusted EBITDA margin expansion. With $672.2m of debt against a market cap near $1bn, a small miss on EBITDA moves the equity a lot — which is exactly why an in-line revenue quarter with a margin beat was worth 20%+ today. If "deferred" turns out to mean "destroyed", the same maths runs in reverse. Also worth noting: nine-month gross margin is still 26.1%, down from 26.8%, so one good quarter hasn't fixed the year yet.

As of 3:20pm ET, 4 Sep 2026. Figures as reported by the sources below, not live market data. Sources: Quanex Q3 2026 results release (StockTitan), Quanex 8-K filing, Investing.com earnings call coverage, Benzinga, StockAnalysis (NX), StockAnalysis (FBIN). For discussion and education only — not investment advice. Verify before acting.